List view / Grid view

Paolo Paoletti

 

news

Two new GSK oral oncology treatments approved by FDA

BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib)…

29 May 2013 | By GlaxoSmithKline

BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets approved by FDA...